You just read:

Braeburn Pharmaceuticals to Conduct First Series of Probuphine® (buprenorphine) Implant Trainings in Washington, D.C. on June 17, 18 and 19 for Qualified Healthcare Providers

News provided by

Braeburn Pharmaceuticals

Jun 14, 2016, 08:00 ET